Latest News

Tech transfer partnership between universities creates company to transform care for millions of women

18th July 2024

All News | Financial News | Partners | Spinouts & Startups | Technology News

Amber Therapeutics successfully closed Series A funding of $100 million (£80 million) from leading healthcare and technology investors in the US and UK.

Oxford University Innovation unveils five recommendations to increase the proportion of women founders to 34 per cent by 2025

14th March 2024

All News | Financial News | Partners | Spinouts & Startups

Oxford University Innovation (OUI) backs International Women’s Day 2024 call for accelerating women’s equality through creation of gender parity in enterprise.

Catalysing innovation: Oxford Innovation Society unveils a new programme

23rd January 2024

Oxford University Innovation announces the much-anticipated relaunch of the Oxford Innovation Society (OIS). With an ambitious 12-month programme of events, OIS aims to fortify connections between Oxford’s companies, investors, industry partners and the vibrant Oxford entrepreneurial ecosystem.

Investor Insights: JP Morgan Conference, latest raises from Genomics and Barinthus Bio

23rd January 2024

All News | Financial News | Spinouts & Startups

It’s a tough climate for raising capital - our Oxford spinout companies are working hard to deliver impressive results. The OUI team recently travelled to the JPM Healthcare conference in San Francisco to connect our spinout leaders with US and global life science investors.

Oxford University Innovation Responds to the U.K. Government’s Independent Review of University Spin-Out Companies

21st November 2023

All News | Financial News | Partners | Spinouts & Startups | Technology News

Oxford University Innovation (OUI) welcomes the Independent Review of University Spin-out companies, published today.

University-led collaboration aims to supercharge UK Social Ventures

9th October 2023

All News | Financial News | Spinouts & Startups

Funding via the Connecting Capability Fund will provide acceleration of support for the UK university social venture sector.

Professor Robert MacLaren's retinal gene therapy.

Beacon Therapeutics spun out by Syncona and Oxford raises £96 million for retinal gene therapy

12th June 2023

All News | Financial News | Spinouts & Startups | Technology News

Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.

Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness

12th June 2023

All News | Financial News | Spinouts & Startups | Technology News

Oxford University retains No. 1 spot for spinouts

22nd May 2023

All News | Financial News | Spinouts & Startups

The 2023 Spotlight on Spinouts report once again underlines Oxford’s leading position in spinout creation. The report underlines Oxford Science Enterprises’ positive impact on Oxford’s spinout community, while investments into Oxford spinouts remain high, despite UK-wide downturn.

Top universities boost investor confidence with new spinout framework to spur economic growth

24th April 2023

All News | Financial News | Spinouts & Startups

The University of Oxford partners with top universities and investors to agree terms which will greatly increase the UK’s capacity to turn world-leading research into spinouts that will generate economic growth and societal impact.

News

Ready to get in touch?